EP3600326
DOSE AND REGIMEN FOR AN HDM2-P53 INTERACTION INHIBITOR IN HEMATOLOGICAL TUMORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.3.2018EP published:
25.1.2023EP application number:
18718926.1
EPO information:
European Patent Register
Max expiry date:
28.3.2038
Title in English:
DOSE AND REGIMEN FOR AN HDM2-P53 INTERACTION INHIBITOR IN HEMATOLOGICAL TUMORSLanguage of the patent:
English
Timeline
Today
29.3.2018EP application
25.1.2023EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
FERRETTI, StephaneAddress:
4002 Basel, CH
Name:
GUERREIRO, NelsonAddress:
4056 Basel, CH
Name:
JEAY, SebastienAddress:
4002 Basel, CH
Name:
JULLION, AstridAddress:
4056 Basel, CH
Name:
MEILLE, ChristopheAddress:
4056 Basel, CH
Name:
WUERTHNER, JensAddress:
4002 Basel, CH
Name:
FABRE, ClaireAddress:
4002 Basel, CH
Priority
Number:
201762479397 PDate:
31.3.2017Country:
US
Classification
Categories:
A61K 31/506, A61K 45/06, A61P 35/02